# U.S. Continental Marketing, Inc. – FDA Inspection, Oct 30, 2018

Source: https://www.keypedia.com/records/fda_inspections/us-continental-marketing-inc/5e865a6b-c9f0-4293-b6a6-9a95b169e544
Source feed: FDA_Inspections

> FDA inspection 1070430 of U.S. Continental Marketing, Inc., October 30, 2018. Classification: Official Action Indicated (OAI). 6 citations under 21 CFR part 211. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1070430
- Company Name: U.S. Continental Marketing, Inc.
- Inspection Date: 2018-10-30
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 6
- Enforcement Type: WARNING_LETTER

## Related Documents

- [FDA Inspection 1175769 - 2022-07-21](https://www.keypedia.com/records/fda_inspections/us-continental-marketing-inc/76d0784f-cad7-4f1a-8eb4-6b7b23f7b05e)

## Related Officers

- [Stephanie A. Slater](https://www.keypedia.com/people/stephanie-a-slater/f356e65c-3398-4688-8b86-4dcd4b9ae83b)

Company: https://www.keypedia.com/companies/us-continental-marketing-inc/2202462e-0004-4f6d-bc79-0bd1c3ac88c2

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
